Prostate cancer: to screen or not to screen?

Area of Science:

• Urology
• Oncology
• Public Health

Background:

• Prostate cancer screening in asymptomatic men over 50 is a debated topic.
• Balancing the benefits and harms of screening is essential for clinical practice.

Purpose of the Study:

• To review the medical and economic arguments for and against prostate cancer screening in asymptomatic men over 50.
• To provide evidence-based recommendations on prostate cancer screening strategies.

Main Methods:

• Literature review of medical and economic evidence.
• Analysis of arguments supporting and opposing prostate cancer screening.

Main Results:

• The review highlights significant debate surrounding the efficacy and cost-effectiveness of widespread screening.
• Arguments against screening often cite potential overdiagnosis and overtreatment, while arguments for focus on early detection.

Conclusions:

• Widespread prostate cancer screening for asymptomatic men over 50 is not advised.
• Public education and individualized screening decisions based on patient demand are recommended.